Reversible oral EBV related-lymphoma in a patient with myasthenia graves disease: a case report and review of the literature

---

Copy For Citation

SAÇMACI H., Koseoglu E., Karaatli B., CANÖZ Ö.

ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, vol.11, no.2, pp.162-165, 2020 (ESCI)

• Publication Type: Article / Review
• Volume: 11 Issue: 2
• Publication Date: 2020
• Doi Number: 10.4328/acam.6166
• Journal Name: ANNALS OF CLINICAL AND ANALYTICAL MEDICINE
• Journal Indexes: Emerging Sources Citation Index (ESCI)
• Page Numbers: pp.162-165
• Yozgat Bozok University Affiliated: Yes

Abstract

Thiopurines are widely used for remission maintenance and recurrence prevention in Myasthenia Graves disease (MG). We report a case of a 78-year-old man with MG treated with azathioprine (AZA) for 3 years earlier and who developed an intraoral ulcerated lesion. The biopsy specimen revealed a lymphoma and after discontinuation of AZA therapy the ulcerated lesion showed complete regression at 8 weeks, and no subsequent treatment was required.